Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland
- PMID: 8473515
- PMCID: PMC288155
- DOI: 10.1172/JCI116385
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland
Abstract
The p53 gene was analyzed in tumor specimens obtained from 52 patients with various types of carcinoma of the thyroid gland by a combined molecular and immunocytochemical approach. The histologic types included 37 well-differentiated papillary and follicular carcinomas, 8 poorly differentiated, and 7 undifferentiated carcinomas. The p53 gene was shown to be unaffected in all differentiated tumors by single-strand conformation polymorphism analysis. However, in two out of eight (25%) of poorly differentiated carcinomas and five out of seven (71%) undifferentiated carcinomas, p53 mutations were identified and subsequently characterized by DNA sequencing. One undifferentiated carcinoma displayed two areas with varying degrees of differentiation. The comparative analysis of the p53 gene, in both the more and the less differentiated area of this tumor, clearly showed that the p53 mutation was confined to the latter component of the tumor specimen. These results indicate that mutations of the p53 gene are associated with the most aggressive histologic types of thyroid tumors, such as the undifferentiated carcinoma and, to a certain extent, the poorly differentiated carcinoma, and that the alterations of this gene represent a late genetic event in human thyroid carcinogenesis.
Similar articles
-
Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.Cancer Res. 1992 Mar 1;52(5):1369-71. Cancer Res. 1992. PMID: 1737400
-
Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.Diagn Mol Pathol. 1995 Dec;4(4):256-60. Diagn Mol Pathol. 1995. PMID: 8634781
-
Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.Oncogene. 1996 Aug 15;13(4):687-93. Oncogene. 1996. PMID: 8761289
-
[Unique association of p53 mutations with undifferentiated carcinoma of the thyroid].Nihon Rinsho. 1994 Apr;52(4):1069-74. Nihon Rinsho. 1994. PMID: 8196165 Review. Japanese.
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
Cited by
-
Molecular genetics of thyroid cancer.Genet Res (Camb). 2016 May 13;98:e7. doi: 10.1017/S0016672316000057. Genet Res (Camb). 2016. PMID: 27174043 Free PMC article. Review.
-
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.Curr Treat Options Oncol. 2016 Jun;17(6):30. doi: 10.1007/s11864-016-0404-6. Curr Treat Options Oncol. 2016. PMID: 27139457 Review.
-
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.Oncotarget. 2016 Dec 13;7(50):82757-82769. doi: 10.18632/oncotarget.12634. Oncotarget. 2016. PMID: 27764791 Free PMC article.
-
Molecular pathobiology of thyroid neoplasms.Endocr Pathol. 2002 Winter;13(4):271-88. doi: 10.1385/ep:13:4:271. Endocr Pathol. 2002. PMID: 12665646 Review.
-
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.Am J Pathol. 1999 Dec;155(6):1967-76. doi: 10.1016/S0002-9440(10)65515-0. Am J Pathol. 1999. PMID: 10595926 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous